COVID-19 in Children Seminar Series: COVID Therapeutics

Tuesday, November 24, 2020, 12:00 AM - Thursday, November 24, 2022, 12:00 AM

Internet Enduring Material sponsored by the Stanford University School of Medicine.

This session focuses on COVID therapeutics for children. The presenter also reviews a new paper on the Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-C0V-2 Infection In Danish Mask Wearers. The presenter also focuses on the background, treatment considerations, therapeutics, institution-specific practice guidelines, latest epidemiology for current therapeutics, including: a brief history of remdesivir, SIMPLE severe COVID trial, RECOVERY trial, BLAZE-1 trial, other potential therapeutics and institution specific algorithms.

  Release Date: November 24, 2020
  Review Date: September 8, 2021
  Expiration Date: November 24, 2022
  Estimated Time to Complete: 1 hour
  CME Credits Offered: 1
  Registration Fee: FREE

*Originally recorded 11/19/2020.

Other activities in this series:
Health Disparities and Racism in the Time of COVID
Pediatric Epidemiology and Transmission of COVID-19
COVID-19 and the Primary Care Perspective
COVID-19 in Children: A Conversation 
COVID-19 Vaccines: Development, Trials, Safety & Implications for Children
COVID and Our Schools: Navigating Complex Trade Offs
Peeling Back the Envelope of SARS-CoV-2: Pathogenesis and Immunity

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Participation Credit (1.00 hours)

1. Evaluate the trial data for current therapeutic options in order to determine appropriate strategies when they become available for your pediatric patient population.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

American Medical Association (AMA)
Stanford Medicine designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008. 

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: http://lane.stanford.edu/portals/cultural.html

Reference/Bibliography List
COVID-19 CME Resources https://med.stanford.edu/cme/COVID19.html

The Stanford University School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education.   There are no relevant financial relationships with ACCME-defined commercial interests for anyone who was in control of the content of this activity.